Gene · 285335
SLC9C1: solute carrier family 9 member C1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. SLC9C1: solute carrier family 9 member C1. Genes, record 285335. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/285335
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q4G0N8 | Solute carrier family 9 member C1 | 1,177 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents15
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 64886 | Q4G0N8 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 3979 | Q4G0N8 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 4323 | Q4G0N8 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 4323 | Q4G0N8 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 3979 | Q4G0N8 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 82266 | Q4G0N8 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 185237 | Q4G0N8 | Espacenet |
| US 11078247 B2 | 2021-08-03 | 10621 | Q4G0N8 | Espacenet |
| JP 2019054813 A | 2019-04-11 | 245321 | Q4G0N8 | Espacenet |
| JP 2017121241 A | 2017-07-13 | 245321 | Q4G0N8 | Espacenet |
1 to 10 of 15
See all 15 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants839
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | SLC9C1 papers | Newest fiscal year |
|---|---|---|---|
| P30DK042086 | Center for Interdisciplinary Study of Inflammatory Intestinal DIsorders (C-IID) | 7 | 2025 |
| R01NS048216 | Na/H Exchanger in Microglial Metabolism and Function | 7 | 2025 |
| P30CA062203 | Cancer Center Support Grant | 3 | 2025 |
| P30DK036836 | Diabetes Research Center | 3 | 2025 |
| R01CA207189 | Regulation of Nutrient Stress-Induced Macropinocytosis in Pancreatic Ductal Adenocarcinoma | 3 | 2025 |
| R01HL071158 | Acid, Succinate and Glyoxal Metabolism in Ischemia | 3 | 2025 |
| P30CA016042 | Cancer Center Support Grant | 2 | 2025 |
| P30CA023074 | University of Arizona Cancer Center - Cancer Center Support Grant | 2 | 2025 |
| P30CA030199 | Cancer Center Support Grant (CCSG) | 2 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 2 | 2025 |
1 to 10 of 839Source NIH's project files
See all 839 nih grantsPapers1,657
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SGLT2-Inhibitors and Molecular Signatures of Aortic Valve Remodeling in Severe Aortic Stenosis: The Valve-AS Study. | JACC Basic Transl Sci | 2026 | 42663337 | PubTator, text mining | PubMed |
| NHE1-Mediated Metabolic Reprogramming in Cancer. | Metabolites | 2026 | 41893344 | PubTator, text mining | PubMed |
| pH-regulating Lipiodol Pickering emulsions enhance transarterial embolization therapy via inducing ferroptosis and activating antitumor immunity. | Cell Rep Med | 2026 | 41850231 | PubTator, text mining | PubMed |
| The Role of Renal Na+/H+ Exchange in the Regulation of Acid-Base and Sodium Homeostasis in Premature Infants. | Physiol Res | 2026 | 41811697 | PubTator, text mining | PubMed |
| Calcineurin Homologous Protein 2 Acts as a Conditional Modulator of Migration and Proliferation in Human Bone Sarcoma Cells. | Cancers (Basel) | 2026 | 41749826 | PubTator, text mining | PubMed |
| Dual Role of the Endometrial Microbiome-Immune Axis: From Endometrial Homeostasis to Reproductive Disorders. | Int J Womens Health | 2026 | 41710143 | PubTator, text mining | PubMed |
| Lactate transmission from hypoxic tumor cells promotes macrophage senescence and M2 polarization via the DNMT1-NHE7 axis to accelerate endometrial cancer progression. | Cell Death Dis | 2026 | 41617670 | PubTator, text mining | PubMed |
| Soluble adenylyl cyclase in nonmammalian sperm is directly controlled by pH, not by HCO3- or Ca2. | Proc Natl Acad Sci U S A | 2026 | 41591904 | PubTator, text mining | PubMed |
| Advancements in early biomarkers of acute kidney injury: from traditional indicators to a paradigm shift in lactate metabolism. | Ann Med | 2026 | 41530927 | PubTator, text mining | PubMed |
| The pH perspective of cancer: From warburg's misconception to therapeutic targeting of pH regulating proteins. | Crit Rev Oncol Hematol | 2026 | 41309010 | PubTator, text mining | PubMed |
1 to 10 of 1,657
See all 1,657 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/285335
GET https://conductscience.org/api/genes/v1/285335/patents